Alembic Pharmaceuticals Ltd Share Price
(APLLTD)
Check the latest share price of Alembic Pharmaceuticals Ltd, details on performance, fundamentals, analyst ratings, peer comparison, financials, company news, analysis, and shareholding pattern for informed investing decisions.
as on 04:01PM, 12 May 2025
NSE
Alembic Pharmaceuticals Ltd Performance
Get real-time share price information, day’s high and low, historical returns and market stats.
Day's Low
Day's High
₹875Day's Price Range₹91052 Week's Low
52 Week's High
₹725.252-Week Price Range₹1,303.9
| Returns % | |
| 1 Month Return | + 3.92 % |
| 3 Month Return | + 6.52 % |
| 1 Year Return | -7.73 % |
| 3 Year Return | + 18.62 % |
| 5 Year Return | + 9.96 % |
| Market Stats | |
| Previous Close | ₹900.75 |
| Open | ₹908.90 |
| Volume | 1.18L |
| Upper Circuit | ₹1,080.90 |
| Lower Circuit | ₹720.60 |
Alembic Pharmaceuticals Ltd Fundamentals & Key Indicators
Check the fundamental ratios and key indicators of the company like P/E, P/B, PEG, Dividend yield etc.
Market Cap
₹17,289.69 Cr
Return on Equity (ROE)
14.3
PE Ratio (TTM)
29.7
Return on capital employed (ROCE)
14.13
Industry PE ratio
53.64
Beta (LTM)
0.53
P/B Ratio
3.93
Dividend Yield
1.12
PEG Ratio
-16.78
Quarterly Earnings Growth YOY
-12.11
EPS (TTM)
31.33
Sector
Pharmaceuticals
Book Value
245.14
Technical Analysis
Bullish
View Technical Analysis
How to invest in Alembic Pharmaceuticals Ltd
Investing in Alembic Pharmaceuticals Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Alembic Pharmaceuticals Ltd or APLLTD on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Alembic Pharmaceuticals Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Alembic Pharmaceuticals Ltd with just a few clicks!
Alembic Pharmaceuticals Ltd Stock's Interest Amongst Investors
Alembic Pharmaceuticals Ltd Valuation
Track how the P/E of Alembic Pharmaceuticals Ltd has moved over time to understand valuation trends.
Alembic Pharmaceuticals Ltd in the last 5 years
Lowest (11.53x)
March 23, 2020
Today (29.70x)
May 12, 2025
Industry (53.64x)
May 12, 2025
Highest (53.41x)
January 3, 2023
Today’s Price to Earnings Ratio: 29.70x
Analysts Recommendation on Alembic Pharmaceuticals Ltd
Get updated buy, sell, and hold recommendations by analysts on Alembic Pharmaceuticals Ltd.
based on 11 analysts
54.55%
Buy
45.45%
Hold
0.00%
Sell
54.55% of analysts recommend a 'BUY' rating for Alembic Pharmaceuticals Ltd. Average target price of ₹1015.18
Source: S&P Global Market Intelligence
Analysts Forecast on Alembic Pharmaceuticals Ltd
Get share price movements and forecasts by analysts on Alembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals Ltd price forecast by 11 analysts
Upside of15.41%
High
₹1345
Target
₹1015.18
Low
₹885
Alembic Pharmaceuticals Ltd target price ₹1015.18, a slight upside of 15.41% compared to current price of ₹879.6. According to 11 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Alembic Pharmaceuticals Ltd revenue growth forecast
Expected growth rate Q1, FY2027:31.57%
Forecast
Actual
Including amortisation and stock based compensations
Alembic Pharmaceuticals Ltd EPS growth forecast
EPS estimate Q1, FY2027:47.40%
Forecast
Actual
Source: S&P Global Market Intelligence
Alembic Pharmaceuticals Ltd Financials
Get the annual and quarterly financial summary of Alembic Pharmaceuticals Ltd, including revenue, profit, loss and more.
Alembic Pharmaceuticals Ltd Index Inclusions
Alembic Pharmaceuticals Ltd Earnings and Dividends
View detailed summary of the earnings and dividend history of Alembic Pharmaceuticals Ltd.
Alembic Pharmaceuticals Ltd Earnings Results
Alembic Pharmaceuticals Ltd’s net profit fell -11.96% since last year same period to ₹156.89Cr in the Q4 2024-2025. On a quarterly growth basis, Alembic Pharmaceuticals Ltd has generated 13.34% jump in its net profits since last 3-months.
Read More about Earnings ResultsAlembic Pharmaceuticals Ltd Dividends May,2024
In the quarter ending March 2024, Alembic Pharmaceuticals Ltd has declared dividend of ₹11 - translating a dividend yield of 1.25%.
Read More about Dividends
Alembic Pharmaceuticals Ltd Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Alembic Pharmaceuticals Ltd.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 69.67% | 0.00 | |
| Foreign Institutions | 3.94% | 0.00 | |
| Mutual Funds | 9.2% | 0.00 | |
| Retail Investors | 9.96% | 0.00 | |
| Others | 7.24% | 0.00 |
Alembic Pharmaceuticals Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Alembic Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 17,289.69 | 1.99% | 0.55 | 615 | 6,228 | |
| BUY | 13,480.61 | -5.16% | 0.52 | 413 | 2,013 | |
| BUY | 70,658.34 | 15.68% | 0.56 | 3,168 | 29,001 | |
| HOLD | 89,036.61 | 34.46% | 0.64 | 3,854 | 19,547 | |
| BUY | 63,888.13 | 13.64% | 0.53 | NA | NA |
Alembic Pharmaceuticals Ltd News & Key Events
Latest news and events at one place to help you take investing decisions in Alembic Pharmaceuticals Ltd.
Alembic Pharma Targets FY26 Growth Strategies - 07 May, 2025
Alembic Pharmaceuticals is optimistic about FY26, expecting growth in domestic and US markets, improved EBITDA margins, and strategic product launches despite ongoing challenges in the generics market.Alembic Pharma Reports Mixed Q4 Results and Dividend - 06 May, 2025
Alembic Pharmaceuticals reported a 12% drop in Q4 profit despite a 17% revenue increase. The company announced a 550% dividend, pending approval. Shares fell 2% post-results.Alembic Pharma Secures USFDA Approval for Ticagrelor - 02 May, 2025
Alembic Pharmaceuticals has received USFDA approval for Ticagrelor Tablets, 90 mg, and tentative approval for 60 mg, aimed at preventing heart attacks and strokes. The market size for these drugs is estimated at $1,062 million and $242 million, respectively, for the year ending March 2025.Alembic Pharmaceuticals Receives Positive FDA Inspection Report - 30 Apr, 2025
Alembic Pharmaceuticals received a favorable Establishment Inspection Report from the US FDA for its oncology formulation facility, leading to a notable rise in stock prices. The inspection confirmed compliance for both injectable and oral solid formulations, boosting investor confidence despite recent stock declines.Alembic Pharma Secures USFDA Approval for Carbamazepine - 17 Apr, 2025
Alembic Pharmaceuticals has received final USFDA approval for Carbamazepine Tablets USP, 200 mg, which are therapeutically equivalent to Novartis' Tegretol. The estimated market size is $32 million for the next year.
Insights on Alembic Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 5 quarters, 1.52K Cr → 1.78K Cr (in ₹), with an average increase of 3.9% per quarter
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 69.61% to 69.67% in Mar 2025 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 8.96% to 9.20% in Mar 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, 138.42 Cr → 156.89 Cr (in ₹), with an average increase of 11.8% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, APLLTD stock has moved up by 6.4%
NO EFFECTAgainst Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 150.9% return, outperforming this stock by 127.1%
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 54.1% return, outperforming this stock by 59.6%
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 4.17% to 3.94% in Mar 2025 quarter
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 10.16% to 9.96% in Mar 2025 quarter
About Alembic Pharmaceuticals Ltd
Revenue: ₹1,769.64Cr as on March 2025 (Q1 25)
Net Profit: ₹156.63Cr as on March 2025 (Q1 25)
Listing date: 20 Sep, 2011
Chairperson Name: Chirayu R Amin
| Organisation | Alembic Pharmaceuticals Ltd |
| Headquarters | Vadodara |
| Industry | Pharmaceuticals |
| CEO | Chirayu R Amin |
| E-voting on shares | Click here to vote |
Indian Mutual Funds that own Alembic Pharmaceuticals Ltd
Check out the Mutual Funds with significant holdings in Alembic Pharmaceuticals Ltd.
| Funds | Holdings | Prev. 5M |
|---|---|---|
| Kotak Small Cap Direct Growth | 2.03% | |
| DSP Midcap Fund Direct Plan Growth | 1.6% | |
| Axis Small Cap Fund Direct Growth | 0.54% | |
| DSP Healthcare Fund Direct Growth | 4.38% | |
| DSP ELSS Tax Saver Fund Direct Plan Growth | 0.81% |
FAQs
What is Alembic Pharmaceuticals Ltd price today?
Alembic Pharmaceuticals Ltd share price today stands at ₹879.6, Open: ₹908.9, Previous Close: ₹900.75, High: ₹910, Low: ₹875, 52 Week High: ₹1303.9, 52 Week Low: ₹725.2.
How to Buy Alembic Pharmaceuticals Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Alembic Pharmaceuticals Ltd shares
What are today's traded volumes of Alembic Pharmaceuticals Ltd?
Today's traded volume of Alembic Pharmaceuticals Ltd(APLLTD) is 1.18L.
What is today's market capitalisation of Alembic Pharmaceuticals Ltd?
Today's market capitalisation of Alembic Pharmaceuticals Ltd(APLLTD) is ₹17,289.69 Cr.
What is the 52 Week High and Low Range of Alembic Pharmaceuticals Ltd?
How much percentage Alembic Pharmaceuticals Ltd is down from its 52 Week High?
Alembic Pharmaceuticals Ltd (APLLTD) share price is ₹879.6. It is down -32.54% from its 52 Week High price of ₹1303.9
How much percentage Alembic Pharmaceuticals Ltd is up from its 52 Week low?
Alembic Pharmaceuticals Ltd (APLLTD) share price is ₹879.6. It is up 21.29% from its 52 Week Low price of ₹725.2